Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) appears in 71 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 14,932,063 | 0 | 0.00% | $31,506,653.00 |
| Sands Capital Alternatives, LLC | 31 Dec, 2025 | 3,417,075 | 0 | 0.00% | $7,210,028.00 |
| Franklin Resources Inc | 31 Dec, 2025 | 2,305,096 | 0 | 0.00% | $4,863,753.00 |
| FMR LLC | 31 Dec, 2025 | 2,027,497 | -1,828 | -0.09% | $4,278,019.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 1,782,366 | 891,183 | 100.00% | $3,760,792.00 |
| Laurion Capital Management LP | 31 Dec, 2025 | 1,734,092 | 867,046 | 100.00% | $3,658,934.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,653,772 | 2,300 | 0.14% | $3,489,459.00 |
| Knollwood Investment Advisory, LLC | 31 Dec, 2025 | 1,628,510 | 0 | 0.00% | $3,436,156.00 |
| Alyeska Investment Group, L.P. | 31 Dec, 2025 | 939,603 | 0 | 0.00% | $1,982,562.00 |
| Pathstone Holdings, LLC | 31 Dec, 2025 | 859,110 | 0 | 0.00% | $1,812,722.00 |
| Hudson Bay Capital Management LP | 31 Dec, 2025 | 725,000 | -725,008 | -50.00% | $1,529,750.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 584,143 | -17,573 | -2.92% | $1,232,542.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 423,100 | -161,192 | -27.59% | $892,741.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 421,800 | -1,800 | -0.42% | $889,998.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 410,206 | 11,428 | 2.87% | $865,686.00 |
| SG Americas Securities, LLC | 31 Dec, 2025 | 401,047 | -2,831 | -0.70% | $846.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 373,198 | 158,758 | 74.03% | $787,448.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 345,283 | -148,825 | -30.12% | $728,547.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 254,312 | -11,457 | -4.31% | $536,599.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 240,152 | -187,306 | -43.82% | $506,720.00 |